Meanwhile, we found that MDSCs induced podocyte injury by increasing ROS in lupus nephritis and mammalian target of rapamycin (mTOR) inhibitor INK128 relieved the symptoms of pristane-induced lupus via downregulating the expansion of MDSCs [13, 14]. This evidence concerns the gene MTOR and systemic lupus erythematosus.